"Cancer drug shortages continue to be a serious and growing concern within the Canadian health care system that has been impacting delivery of patient care and treatment for years," the Canadian Cancer Society said in a statement to CTVNews.ca. "We know that shortages are deeply worrying to people with cancer and their families – it is simply not acceptable to go without the medication you need.
According to Health Canada, 2022 also saw shortages of cancer medications like Inqovi, paclitaxel powder, hydroxyurea, Zepzelca, and fludarabine, which have all now been resolved. "The Department continues to monitor both of these critical shortages closely and is working in collaboration with stakeholders to mitigate impacts on patients," a Health Canada spokesperson told CTVNews.ca. "Drug shortages may occur for many reasons, including issues at a manufacturing site, a shipping delay, difficulty in obtaining raw materials or ingredients, a discontinuation of a drug, or an unexpected increase in demand.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CHEK_News - 🏆 59. / 55 Read more »